Skip to main content

Table 1 Definitions and reference ranges for metabolic syndrome according to NCEP-ATP III and AHA/NHLB

From: Prevalence of metabolic syndrome in patients with schizophrenia, and metabolic changes after 3 months of treatment with antipsychotics - results from a German observational study

Risk factor

Defining measure NCEP-ATP III

Defining measure AHA/NHLB

Abdominal obesity

(waist circumference)

  

Men

> 102 cm

≥ 102 cm

Women

> 88 cm

≥ 88 cm

Triglycerides

≥ 150 mg/dL

≥ 150 mg/dL or on drug treatment for elevated triglycerides

High density lipoprotein (HDL)

  

Men

< 40 mg/dL

< 40 mg/dL or on drug treatment for reduced HDL-cholesterol

Women

< 50 mg/dL

< 50 mg/dL or on drug treatment for reduced HDL-cholesterol

Blood pressure

Systolic ≥ 130 or diastolic ≥ 85 mmHg

Systolic ≥ 130 or diastolic ≥ 85 mmHg or on antihypertensive medication

Fasting glucose

≥ 110 mg/dL

≥ 100 mg/dL or on antidiabetic medication

  1. Abbreviations: AHA/NHLB = American Heart Association/National Heart, Lung and Blood Institute; NCEP-ATP III = National Cholesterol Education Program, Adult Treatment Panel 3rd report
  2. According to both definitions, a diagnosis of metabolic syndrome is established if at least three of the above risk factors are present.